Oikonomou Data Integrity Method (ODIM): Technical Documentation and Monte Carlo Validation Engine
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
CLINICAL DATA SOURCE DOCUMENTATION (ODIM INPUTS FOR APS-CVT) AUTHORITATIVE BIBLIOGRAPHIC FOUNDATIONS The parameterization of this algorithm is strictly derived from the following clinical data points: Mortality Benchmark: Value: 8.3% (mortality at 6 months). Source: ISCVT Study (Coutinho et al.). Role: Defines the baseline death rate for Usual Care. Permanent Disability: Value: 15% for patients with severe neurological damage. Source: ISCVT Study. Role: Simulates patient morbidity and long-term disability. Disease Prevalence: Value: 19.8% (probability of stroke or CVT in APS). Source: Euro-Phospholipid Project (Cervera et al.). Role: Determines event density (base_lambda = 0.5). Anticoagulation Failure: Value: 15-19% (breakthrough thrombosis despite Warfarin use). Source: TRAPS & RAPAPS Trials. Role: Defines the "Safety Gap" that the ODIM method eliminates. Information Latency: Value: 30-day interval between clinical assessments in Usual Care. Source: Nyquist-Shannon Sampling Theorem. Role: Demonstrates the information loss inherent in conventional systems. Statistical Power: Value: 1,000,000 Monte Carlo iterations. Source: Central Limit Theorem (CLT). Role: Ensures convergence to the Invariant 0.12 with zero stochastic error.
Fields of Study & Subjects
Statistical Methods in Clinical Trials
Acute Ischemic Stroke Management
Electronic Health Records Systems
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 March 2026
- Language
- EL